Recent Advances in Defining the Genetic Basis of Rheumatoid Arthritis

Annual Review of Genomics and Human Genetics

Volumn 17, Issue , 2016, Pages 273-301

  Terao, Chikashi ^a,b,c,d   Raychaudhuri, Soumya ^a,b,c,e,f   Gregersen, Peter K ^g  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b LABORATORY FOR MOLECULAR MEDICINE   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d KYOTO UNIVERSITY   (Japan)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^g FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

endophenotype; HLA

Indexed keywords

AMINO ACID; AUTOANTIBODY; BIOLOGICAL MARKER; HLA ANTIGEN; HLA DRB1 ANTIGEN;

ALLELE; ANTIBODY TITER; ARTICLE; CELLS BY BODY ANATOMY; CLINICAL OUTCOME; ENVIRONMENTAL FACTOR; GENE MAPPING; GENETIC REGULATION; GENETIC VARIABILITY; GENOME; GENOTYPE ENVIRONMENT INTERACTION; HERITABILITY; HLA SYSTEM; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PHENOTYPE; PREDICTION; QUANTITATIVE TRAIT LOCUS; RHEUMATOID ARTHRITIS; SERODIAGNOSIS; TREATMENT RESPONSE; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; PATHOLOGY;

ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; GENETIC PREDISPOSITION TO DISEASE; HLA-DRB1 CHAINS; HUMANS;

EID: 84984863636     PISSN: 15278204     EISSN: 1545293X     Source Type: Book Series    
DOI: 10.1146/annurev-genom-090314-045919     Document Type: Article

References (185)

1. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, et al. 2010. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 62:2569-81
2. Amara K, Steen J, Murray F, Morbach H, Fernandez-Rodriguez BM, et al. 2013. Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition. J. Exp. Med. 210:445-55
3. Arkema EV, Lu B, Malspeis S, Karlson EW, Costenbader KH. 2015. Monocyte chemotactic protein-1 elevation prior to the onset of rheumatoid arthritis among women. Biomark. Med. 9:723-29
4. Balsa A, Cabezon A, Orozco G, Cobo T, Miranda-Carus E, et al. 2010. Influence of HLA DRB1 alleles in the susceptibility of rheumatoid arthritis and the regulation of antibodies against citrullinated proteins and rheumatoid factor. Arthritis Res. Ther. 12:R62
5. Bang SY, Na YJ, Kim K, Joo YB, Park Y, et al. 2014. Targeted exon sequencing fails to identify rare coding variants with large effect in rheumatoid arthritis. Arthritis Res. Ther. 16:447
6. Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, et al. 2004. Amissense singlenucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 75:330-37
7. Boechat AL, Ogusku MM, Sadahiro A, dos Santos MC. 2013. Association between the PTPN22 1858C/T gene polymorphism and tuberculosis resistance. Infect. Genet. Evol. 16:310-13
8. Bossini-Castillo L, de Kovel C, Källberg H, van 't Slot R, Italiaander A, et al. 2015. A genome-wide association study of rheumatoid arthritis without antibodies against citrullinated peptides. Ann. Rheum. Dis. 74:e15
9. Bottini N, Peterson EJ. 2014. Tyrosine phosphatase PTPN22: multifunctional regulator of immune signaling, development, and disease. Annu. Rev. Immunol. 32:83-119
10. Buenrostro JD, Wu B, Chang HY, Greenleaf WJ. 2015. ATAC-seq: a method for assaying chromatin accessibility genome-wide. Curr. Protoc. Mol. Biol. 109:21.29.1-9
11. Byng-Maddick R, Ehrenstein MR. 2015. The impact of biological therapy on regulatory T cells in rheumatoid arthritis. Rheumatology 54:768-75
12. Catrina AI, Ytterberg AJ, Reynisdottir G, Malmström V, Klareskog L. 2014. Lungs, joints and immunity against citrullinated proteins in rheumatoid arthritis. Nat. Rev. Rheumatol. 10:645-53
13. Chang HH, Dwivedi N, Nicholas AP, Ho IC. 2015. TheW620 polymorphism in PTPN22 disrupts its interaction with peptidylarginine deiminase type 4 and enhances citrullination and NETosis. Arthritis Rheumatol. 67:2323-34
14. Cheng T, Choi Y, Finkel TH, Tsao PY, Ji MQ, Eisenberg RA. 2013. Tumor necrosis factor receptorassociated factor 1 influences KRN/I-Ag7 mouse arthritis autoantibody production. J. Clin. Immunol. 33:759-66
15. Chung WS, Peng CL, Lin CL, Chang YJ, Chen YF, et al. 2014. Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study. Ann. Rheum. Dis. 73:1774-80
16. Churov AV, Oleinik EK, Knip M. 2015. MicroRNAs in rheumatoid arthritis: altered expression and diagnostic potential. Autoimmun. Rev. 14:1029-37
17. Cohen J, Pertsemlidis A, Kotowski IK, Graham R, Garcia CK, Hobbs HH. 2005. Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9. Nat. Genet. 37:161-65
18. Cui J, Stahl EA, Saevarsdottir S, Miceli C, Diogo D, et al. 2013. Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis. PLOS Genet. 9:e1003394
19. Cui J, Taylor KE, Lee YC, Källberg H, Weinblatt ME, et al. 2014. The influence of polygenic risk scores on heritability of anti-CCP level in RA. Genes Immun. 15:107-14
20. de Rooy DP, Zhernakova A, Tsonaka R, Willemze A, Kurreeman BA, et al. 2014. A genetic variant in the region of MMP-9 is associated with serum levels and progression of joint damage in rheumatoid arthritis. Ann. Rheum. Dis. 73:1163-69
21. Demoruelle MK, Parish MC, Derber LA, Kolfenbach JR, Hughes-Austin JM, et al. 2013. Performance of anti-cyclic citrullinated peptide assays differs in subjects at increased risk of rheumatoid arthritis and subjects with established disease. Arthritis Rheum. 65:2243-52
22. Dendrou CA, Plagnol V, Fung E, Yang JH, Downes K, et al. 2009. Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource. Nat. Genet. 41:1011-15
23. Di Meglio P, Di Cesare A, Laggner U, Chu CC, Napolitano L, et al. 2011. The IL23R R381Q gene variant protects against immune-mediated diseases by impairing IL-23-induced Th17 effector response in humans. PLOS ONE 6:e17160
24. Dilthey AT, Moutsianas L, Leslie S, McVean G. 2011. HLA∗IMP - an integrated framework for imputing classical HLA alleles from SNP genotypes. Bioinformatics 27:968-72
25. Diogo D, Bastarache L, Liao KP, Graham RR, Fulton RS, et al. 2015. TYK2 protein-coding variants protect against rheumatoid arthritis and autoimmunity, with no evidence of major pleiotropic effects on non-autoimmune complex traits. PLOS ONE 10:e0122271
26. Diogo D, Kurreeman F, Stahl EA, Liao KP, Gupta N, et al. 2013. Rare, low-frequency, and common variants in the protein-coding sequence of biological candidate genes from GWASs contribute to risk of rheumatoid arthritis. Am. J. Hum. Genet. 92:15-27
27. Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, et al. 2004. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFαtherapy. J. Exp. Med. 200:277-85
28. Essouma M, Noubiap JJ. 2015. Is air pollution a risk factor for rheumatoid arthritis? J. Inflamm. 12:48
29. Eyre S, Bowes J, Diogo D, Lee A, Barton A, et al. 2012. High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nat. Genet. 44:1336-40
30. Eyre S, Ke X, Lawrence R, Bowes J, Panoutsopoulou K, et al. 2011. Examining the overlap between genome-wide rare variant association signals and linkage peaks in rheumatoid arthritis. Arthritis Rheum. 63:1522-26
31. Farh KK, Marson A, Zhu J, Kleinewietfeld M, Housley WJ, et al. 2015. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 518:337-43
32. Finucane HK, Bulik-Sullivan B, Gusev A, Trynka G, Reshef Y, et al. 2015. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat. Genet. 47:1228-35
33. Firestein GS. 2003. Evolving concepts of rheumatoid arthritis. Nature 423:356-61
34. Fries JF, Wolfe F, Apple R, Erlich H, Bugawan T, et al. 2002. HLA-DRB1 genotype associations in 793 white patients from a rheumatoid arthritis inception cohort: frequency, severity, and treatment bias. Arthritis Rheum. 46:2320-29
35. Frisell T, Holmqvist M, Källberg H, Klareskog L, Alfredsson L, Askling J. 2013. Familial risks and heritability of rheumatoid arthritis: role of rheumatoid factor/anti-citrullinated protein antibody status, number and type of affected relatives, sex, and age. Arthritis Rheum. 65:2773-82
36. Gan RW, Trouw LA, Shi J, Toes RE, Huizinga TW, et al. 2015. Anti-carbamylated protein antibodies are present prior to rheumatoid arthritis and are associated with its future diagnosis. J. Rheumatol. 42:572-79
37. Gan RW, Young KA, Zerbe GO, Demoruelle MK, Weisman MH, et al. 2016. Lower omega-3 fatty acids are associated with the presence of anti-cyclic citrullinated peptide autoantibodies in a population at risk for future rheumatoid arthritis: a nested case-control study. Rheumatology 55:367-76
38. Gibofsky A, Winchester RJ, Patarroyo M, Fotino M, Kunkel HG. 1978. Disease associations of the Ialike human alloantigens. Contrasting patterns in rheumatoid arthritis and systemic lupus erythematosus. J. Exp. Med. 148:1728-32
39. Gourh P, Agarwal SK, Martin E, Divecha D, Rueda B, et al. 2010. Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations. J. Autoimmun. 34:155-62
40. Gregersen PK, Amos CI, Lee AT, Lu Y, Remmers EF, et al. 2009. REL, encoding a member of the NF-κB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis. Nat. Genet. 41:820-23
41. Gregersen PK, Klein G, Keogh M, Kern M, DeFranco M, et al. 2015. The Genotype and Phenotype (GaP) registry: a living biobank for the analysis of quantitative traits. Immunol. Res. 1:107-12
42. Gregersen PK, Manjarrez-Orduño N. 2013. FOXO in the hole: leveraging GWAS for outcome and function. Cell 155:11-12
43. Gregersen PK, Silver J, Winchester RJ. 1987. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 30:1205-13
44. Gusev A, Bhatia G, Zaitlen N, Vilhjalmsson BJ, Diogo D, et al. 2013. Quantifying missing heritability at known GWAS loci. PLOS Genet. 9:e1003993
45. Hall FC, Weeks DE, Camilleri JP, Williams LA, Amos N, et al. 1996. Influence of the HLA-DRB1 locus on susceptibility and severity in rheumatoid arthritis. QJM 89:821-29
46. Han B, Diogo D, Eyre S, Källberg H, Zhernakova A, et al. 2014. Fine mapping seronegative and seropositive rheumatoid arthritis to shared and distinctHLA alleles by adjusting for the effects of heterogeneity. Am. J. Hum. Genet. 94:522-32
47. Hasegawa K, Martin F, Huang G, Tumas D, Diehl L, Chan AC. 2004. PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells. Science 303:685-89
48. Hemminki K, Li X, Sundquist J, Sundquist K. 2009. Familial associations of rheumatoid arthritis with autoimmune diseases and related conditions. Arthritis Rheum. 60:661-68
49. Hensvold AH, Magnusson PK, Joshua V, Hansson M, Israelsson L, et al. 2013. Environmental and genetic factors in the development of anticitrullinated protein antibodies (ACPAs) and ACPA-positive rheumatoid arthritis: an epidemiological investigation in twins. Ann. Rheum. Dis. 74:375-80
50. Hom G, Graham RR, Modrek B, Taylor KE, Ortmann W, et al. 2008. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N. Engl. J. Med. 358:900-9
51. Hu X, Kim H, Raj T, Brennan PJ, Trynka G, et al. 2014. Regulation of gene expression in autoimmune disease loci and the genetic basis of proliferation in CD4+ effector memory T cells. PLOS Genet. 10:e1004404
52. Hu X, Kim H, Stahl E, Plenge R, Daly M, Raychaudhuri S. 2011. Integrating autoimmune risk loci with gene-expression data identifies specific pathogenic immune cell subsets. Am. J. Hum. Genet. 89:496-506
53. Hughes-Austin JM, Deane KD, Derber LA, Kolfenbach JR, Zerbe GO, et al. 2013. Multiple cytokines and chemokines are associated with rheumatoid arthritis-related autoimmunity in first-degree relatives without rheumatoid arthritis: Studies of the Aetiology of Rheumatoid Arthritis (SERA). Ann. Rheum. Dis. 72:901-7
54. Irigoyen P, Lee AT, Wener MH, Li W, Kern M, et al. 2005. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles. Arthritis Rheum. 52:3813-18
55. Jawaheer D, Li W, Graham RR, Chen W, Damle A, et al. 2002. Dissecting the genetic complexity of the association between human leukocyte antigens and rheumatoid arthritis. Am. J. Hum. Genet. 71:585-94
56. Jia X, Han B, Onengut-Gumuscu S, Chen WM, Concannon PJ, et al. 2013. Imputing amino acid polymorphisms in human leukocyte antigens. PLOS ONE 8:e64683
57. Jiang L, Yin J, Ye L, Yang J, Hemani G, et al. 2014. Novel risk loci for rheumatoid arthritis in Han Chinese and congruence with risk variants in Europeans. Arthritis Rheumatol. 66:1121-32
58. Jiang X, Trouw LA, van Wesemael TJ, Shi J, Bengtsson C, et al. 2014. Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies. Ann. Rheum. Dis. 73:1761-68
59. Johansson M, Arlestig L, Hallmans G, Rantapaa-Dahlqvist S. 2006. PTPN22 polymorphism and anticyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease. Arthritis Res. Ther. 8:R19
60. Källberg H, Padyukov L, Plenge RM, Rönnelid J, Gregersen PK, et al. 2007. Gene-gene and geneenvironment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. Am. J. Hum. Genet. 80:867-75
61. Kim SJ, Gregersen PK, Diamond B. 2013. Regulation of dendritic cell activation by microRNA let-7c and BLIMP1. J. Clin. Investig. 123:823-33
62. Klareskog L, Stolt P, Lundberg K, Källberg H, Bengtsson C, et al. 2006. A new model for an etiology of rheumatoid arthritis: Smoking may triggerHLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 54:38-46
63. Knevel R, de Rooy DPC, Zhernakova A, Grondal G, Krabben A, et al. 2013. Association of variants in IL2RA with progression of joint destruction in rheumatoid arthritis. Arthritis Rheum. 65:1684-93
64. Knevel R, Grondal G, Huizinga TW, Visser AW, Jonsson H, et al. 2012. Genetic predisposition of the severity of joint destruction in rheumatoid arthritis: a population-based study. Ann. Rheum. Dis. 71:707-9
65. Knevel R, Klein K, Somers K, Ospelt C, Houwing-Duistermaat JJ, et al. 2014. Identification of a genetic variant for joint damage progression in autoantibody-positive rheumatoid arthritis. Ann. Rheum. Dis. 73:2038-46
66. Kochi Y, Okada Y, Suzuki A, Ikari K, Terao C, et al. 2010. A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility. Nat. Genet. 42:515-19
67. Kochi Y, Yamada R, Suzuki A, Harley JB, Shirasawa S, et al. 2005. A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat. Genet. 37:478-85
68. Kokkonen H, Mullazehi M, Berglin E, Hallmans G, Wadell G, et al. 2011. Antibodies of Ig G, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis. Arthritis Res. Ther. 13:R13
69. Kolfenbach JR, Deane KD, Derber LA, O'Donnell CI, Gilliland WR, et al. 2010. Autoimmunity to peptidyl arginine deiminase type 4 precedes clinical onset of rheumatoid arthritis. Arthritis Rheum. 62:2633-39
70. Krabben A, Wilson AG, de Rooy DP, Zhernakova A, Brouwer E, et al. 2013. Association of genetic variants in the IL4 and IL4R genes with the severity of joint damage in rheumatoid arthritis: a study in seven cohorts. Arthritis Rheum. 65:3051-57
71. Krintel SB, Palermo G, Johansen JS, Germer S, Essioux L, et al. 2012. Investigation of single nucleotide polymorphisms and biological pathways associated with response to TNFα inhibitors in patients with rheumatoid arthritis. Pharmacogenet. Genom. 22:577-89
72. Kroot EJ, de Jong BA, van Leeuwen MA, Swinkels H, van den Hoogen FH, et al. 2000. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum. 43:1831-35
73. Kurreeman FA, Padyukov L, Marques RB, Schrodi SJ, Seddighzadeh M, et al. 2007. A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis. PLOS Med. 4:e278
74. Laki J, Lundström E, Snir O, Rönnelid J, Ganji I, et al. 2012. Very high levels of anti-citrullinated protein antibodies are associated with HLA-DRB1∗15 non-shared epitope allele in patients with rheumatoid arthritis. Arthritis Rheum. 64:2078-84
75. Lawrence JS. 1970. Heberden Oration, 1969. Rheumatoid arthritis - nature or nurture? Ann. Rheum. Dis. 29:357-79
76. Lee HS, Irigoyen P, Kern M, Lee A, Batliwalla F, et al. 2007. Interaction between smoking, the shared epitope, and anti-cyclic citrullinated peptide: a mixed picture in three large North American rheumatoid arthritis cohorts. Arthritis Rheum. 56:1745-53
77. Lee JC, Espeli M, Anderson CA, Linterman MA, Pocock JM, et al. 2013. Human SNP links differential outcomes in inflammatory and infectious disease to a FOXO3-regulated pathway. Cell 155:57-69
78. Lenz TL, Deutsch AJ, Han B, Hu X, Okada Y, et al. 2015. Widespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseases. Nat. Genet. 47:1085-90
79. Lewis-Faning E. 1950. Report on an enquiry into the aetiological factors associated with rheumatoid arthritis. Ann. Rheum. Dis. 9(Suppl.):1-94
80. Linn-Rasker SP, van der Helm-van Mil AH, van Gaalen FA, Kloppenburg M, de Vries RR, et al. 2006. Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLADRB1 shared epitope alleles. Ann. Rheum. Dis. 65:366-71
81. Liu C, Batliwalla F, Li W, Lee A, Roubenoff R, et al. 2008. Genome-wide association scan identifies candidate polymorphisms associated with differential response to anti-TNF treatment in rheumatoid arthritis. Mol. Med. 14:575-81
82. Lu B, Hiraki LT, Sparks JA, Malspeis S, Chen CY, et al. 2014. Being overweight or obese and risk of developing rheumatoid arthritis among women: a prospective cohort study. Ann. Rheum. Dis. 73:1914-22
83. Lundberg K, Bengtsson C, Kharlamova N, Reed E, Jiang X, et al. 2012. Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anticitrullinated protein/peptide antibody fine specificity profile. Ann. Rheum. Dis. 72:652-58
84. Lundström E, Källberg H, Alfredsson L, Klareskog L, Padyukov L. 2009. Gene-environment interaction between theDRB1 shared epitope and smoking in the risk of anti-citrullinated protein antibody-positive rheumatoid arthritis: All alleles are important. Arthritis Rheum. 60:1597-603
85. MacGregor AJ, Snieder H, Rigby AS, Koskenvuo M, Kaprio J, et al. 2000. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum. 43:30-37
86. Mahdi H, Fisher BA, Källberg H, Plant D, Malmström V, et al. 2009. Specific interaction between genotype, smoking and autoimmunity to citrullinated α-enolase in the etiology of rheumatoid arthritis. Nat. Genet. 41:1319-24
87. McAllister K, Yarwood A, Bowes J, Orozco G, Viatte S, et al. 2013. Identification of BACH2 and RAD51B as rheumatoid arthritis susceptibility loci in a meta-analysis of genome-wide data. Arthritis Rheum. 65:3058-62
88. Morgan AW, Thomson W, Martin SG, Carter AM, Erlich HA, et al. 2009. Reevaluation of the interaction between HLA-DRB1 shared epitope alleles, PTPN22, and smoking in determining susceptibility to autoantibody-positive and autoantibody-negative rheumatoid arthritis in a large UK Caucasian population. Arthritis Rheum. 60:2565-76
89. Nadkarni S, Mauri C, Ehrenstein MR. 2007. Anti-TNF-αtherapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β. J. Exp. Med. 204:33-39
90. Nejentsev S, Walker N, Riches D, Egholm M, Todd JA. 2009. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 324:387-89
91. Nelson JL, Mickelson E, Masewicz S, Barrington R, Dugowson C, et al. 1991. Dw14(DRB1∗0404) is a Dw4-dependent risk factor for rheumatoid arthritis. Rethinking the "shared epitope" hypothesis. Tissue Antigens 38:145-51
92. Neovius M, Simard JF, Askling J (ARTIS Study Group). 2011. Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden. Ann. Rheum. Dis. 70:624-29
93. Nepom GT, Holbeck SL, Seyfried CE, Wilske KR, Nepom BS. 1986. Identification of HLA-Dw14 genes in DR4+ rheumatoid arthritis. Lancet 328:1002-5
94. Nienhuis RL, Mandema E. 1964. A new serum factor in patients with rheumatoid arthritis: the antiperinuclear factor. Ann. Rheum. Dis. 23:302-5
95. Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, et al. 2007. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann. Intern. Med. 146:797-808
96. Nordmark G, Kristjansdottir G, Theander E, Appel S, Eriksson P, et al. 2011. Association of EBF1, FAM167A(C8orf13)-BLK and TNFSF4 gene variants with primary Sjogren's syndrome. Genes Immun. 12:100-9
97. Ohmura K, Terao C, Maruya E, Katayama M, Matoba K, et al. 2010. Anti-citrullinated peptide antibodynegative RA is a genetically distinct subset: a definitive study using only bone-erosive ACPA-negative rheumatoid arthritis. Rheumatology 49:2298-304
98. Okada Y, Kim K, Han B, Pillai NE, Ong RT, et al. 2014. Risk for ACPA-positive rheumatoid arthritis is driven by shared HLA amino acid polymorphisms in Asian and European populations. Hum. Mol. Genet. 23:6916-26
99. Okada Y, Suzuki A, Yamada R, Kochi Y, Shimane K, et al. 2010. HLA-DRB1∗0901 lowers anti-cyclic citrullinated peptide antibody levels in Japanese patients with rheumatoid arthritis. Ann. Rheum. Dis. 69:1569-70
100. Okada Y, Terao C, Ikari K, Kochi Y, Ohmura K, et al. 2012. Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population. Nat. Genet. 44:511-16
101. Okada Y, Wu D, Trynka G, Raj T, Terao C, et al. 2014. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506:376-81
102. Padyukov L, Seielstad M, Ong RT, Ding B, Rönnelid J, et al. 2011. A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis. Ann. Rheum. Dis. 70:259-65
103. Pedersen M, Jacobsen S, Garred P, Madsen HO, Klarlund M, et al. 2007. Strong combined geneenvironment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis: a nationwide casecontrol study in Denmark. Arthritis Rheum. 56:1446-53
104. Pillai NE, Okada Y, Saw WY, Ong RT, Wang X, et al. 2014. PredictingHLAalleles from high-resolution SNP data in three Southeast Asian populations. Hum. Mol. Genet. 23:4443-51
105. Plant D, Bowes J, Potter C, Hyrich KL, Morgan AW, et al. 2011. Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven loci. Arthritis Rheum. 63:645-53
106. Plenge RM, Cotsapas C, Davies L, Price AL, de Bakker PI, et al. 2007. Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat. Genet. 39:1477-82
107. Plenge RM, Seielstad M, Padyukov L, Lee AT, Remmers EF, et al. 2007. TRAF1-C5 as a risk locus for rheumatoid arthritis - a genomewide study. N. Engl. J. Med. 357:1199-209
108. Pouget JG, Gonçalves VF, Schizophr. Work. Group Psychiatr. Genom. Consort., Spain SL, Finucane HK, et al. 2015. Genome-wide association studies suggest limited immune gene enrichment in schizophrenia compared to six immune diseases. BioRxiv. doi: 10.1101/030411
109. Qu K, Zaba LC, Giresi PG, Li R, Longmire M, et al. 2015. Individuality and variation of personal regulomes in primary human T cells. Cell Syst. 1:51-61
110. Rawlings DJ, Dai X, Buckner JH. 2015. The role of PTPN22 risk variant in the development of autoimmunity: finding common ground between mouse and human. J. Immunol. 194:2977-84
111. Raychaudhuri S, Remmers EF, Lee AT, Hackett R, Guiducci C, et al. 2008. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat. Genet. 40:1216-23
112. Raychaudhuri S, Sandor C, Stahl EA, Freudenberg J, Lee HS, et al. 2012. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat. Genet. 44:291-96
113. Raychaudhuri S, Thomson BP, Remmers EF, Eyre S, Hinks A, et al. 2009. Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. Nat. Genet. 41:1313-18
114. Remmers EF, Plenge RM, Lee AT, Graham RR, Hom G, et al. 2007. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N. Engl. J. Med. 357:977-86
115. Reynolds RJ, Ahmed AF, Danila MI, Hughes LB, Consort. Longitud. Eval. Afr. Am. Early Rheum. Arthritis Investig., et al. 2014. HLA-DRB1-associated rheumatoid arthritis risk at multiple levels in African Americans: hierarchical classification systems, amino acid positions, and residues. Arthritis Rheumatol. 66:3274-82
116. Rivas MA, Beaudoin M, Gardet A, Stevens C, Sharma Y, et al. 2011. Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat. Genet. 43:1066-73
117. Rose HM, Ragan C, Pearce E, Lipman MO. 1948. Differential agglutination of normal and sensitized sheep erythrocytes by sera of patients with rheumatoid arthritis. Proc. Soc. Exp. Biol. Med. 68:1-6
118. Saijo K, Schmedt C, Su IH, Karasuyama H, Lowell CA, et al. 2003. Essential role of Src-family protein tyrosine kinases in NF-κB activation during B cell development. Nat. Immunol. 4:274-79
119. Sakaguchi N, Takahashi T, Hata H, Nomura T, Tagami T, et al. 2003. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 426:454-60
120. Samuelson EM, Laird RM, Maue AC, Rochford R, Hayes SM. 2012. Blk haploinsufficiency impairs the development, but enhances the functional responses, of MZ B cells. Immunol. Cell Biol. 90:620-29
121. Samuelson EM, Laird RM, Papillion AM, Tatum AH, Princiotta MF, Hayes SM. 2014. Reduced B lymphoid kinase (Blk) expression enhances proinflammatory cytokine production and induces nephrosis in C57BL/6-lpr/lpr mice. PLOS ONE 9:e92054
122. Scally SW, Petersen J, Law SC, Dudek NL, Nel HJ, et al. 2013. A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis. J. Exp. Med. 210:2569-82
123. Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ. 1998. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J. Clin. Investig. 101:273-81
124. Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, et al. 2000. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 43:155-63
125. Scherer HU, van der Woude D, Willemze A, Trouw LA, Knevel R, et al. 2011. Distinct ACPA fine specificities, formed under the influence of HLA shared epitope alleles, have no effect on radiographic joint damage in rheumatoid arthritis. Ann. Rheum. Dis. 70:1461-64
126. Scott IC, Seegobin SD, Steer S, Tan R, Forabosco P, et al. 2013. Predicting the risk of rheumatoid arthritis and its age of onset through modelling genetic risk variants with smoking. PLOS Genet. 9:e1003808
127. Seidl C, Donner H, Fischer B, Usadel KH, Seifried E, et al. 1998. CTLA4 codon 17 dimorphism in patients with rheumatoid arthritis. Tissue Antigens 51:62-66
128. Shi J, Knevel R, Suwannalai P, van der Linden MP, Janssen GM, et al. 2011. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. PNAS 108:17372-77
129. Shi J, van de Stadt LA, Levarht EW, Huizinga TW, Toes RE, et al. 2013. Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis. Arthritis Rheum. 65:911-15
130. Shi J, van Veelen PA, Mahler M, Janssen GM, Drijfhout JW, et al. 2014. Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies. Autoimmun. Rev. 13:225-30
131. Shmerling RH, Delbanco TL. 1991. The rheumatoid factor: an analysis of clinical utility. Am. J. Med. 91:528-34
132. Simpfendorfer KR, Armstead BE, Shih A, Li W, Curran M, et al. 2015. Autoimmune disease-associated haplotypes of BLK exhibit lowered thresholds for B cell activation and expansion of Ig class-switched B cells. Arthritis Rheumatol. 67:2866-76
133. Simpfendorfer KR, Olsson LM, Manjarrez-Orduño N, Khalili H, Simeone AM, et al. 2012. The autoimmunity-associated BLK haplotype exhibits cis-regulatory effects onmRNAand protein expression that are prominently observed in B cells early in development. Hum. Mol. Genet. 21:3918-25
134. Snir O, Gomez-Cabrero D, Montes A, Perez-Pampin E, Gómez-Reino JJ, et al. 2014. Non-HLA genes PTPN22, CDK6 and PADI4 are associated with specific autoantibodies in HLA-defined subgroups of rheumatoid arthritis. Arthritis Res. Ther. 16:414
135. Somers EC, Antonsen S, Pedersen L, Sorensen HT. 2013. Parental history of lupus and rheumatoid arthritis and risk in offspring in a nationwide cohort study: Does sex matter? Ann. Rheum. Dis. 72:525-29
136. Speed D, Hemani G, Johnson MR, Balding DJ. 2012. Improved heritability estimation from genomewide SNPs. Am. J. Hum. Genet. 91:1011-21
137. Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, et al. 2010. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat. Genet. 42:508-14
138. Stahl EA, Wegmann D, Trynka G, Gutierrez-Achury J, Do R, et al. 2012. Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis. Nat. Genet. 44:483-89
139. Stanford SM, Bottini N. 2014. PTPN22: the archetypal non-HLA autoimmunity gene. Nat. Rev. Rheumatol. 10:602-11
140. Stastny P. 1976. Mixed lymphocyte cultures in rheumatoid arthritis. J. Clin. Investig. 57:1148-57
141. Stastny P. 1978. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N. Engl. J. Med. 298:869-71
142. Stein EA, Mellis S, Yancopoulos GD, Stahl N, Logan D, et al. 2012. Effect of a monoclonal antibody to PCSK9 on LDL cholesterol. N. Engl. J. Med. 366:1108-18
143. Sugiyama D, Nishimura K, Tamaki K, Tsuji G, Nakazawa T, et al. 2010. Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies. Ann. Rheum. Dis. 69:70-81
144. Suzuki A, Yamada R, Chang X, Tokuhiro S, Sawada T, et al. 2003. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat. Genet. 34:395-402
145. Suzuki A, Yamada R, Kochi Y, Sawada T, Okada Y, et al. 2008. Functional SNPs in CD244 increase the risk of rheumatoid arthritis in a Japanese population. Nat. Genet. 40:1224-29
146. Suzuki T, Ikari K, Yano K, Inoue E, Toyama Y, et al. 2013. PADI4 and HLA-DRB1 are genetic risks for radiographic progression in RA patients, independent of ACPA status: results from the IORRA cohort study. PLOS ONE 8:e61045
147. Svard A, Skogh T, Alfredsson L, Ilar A, Klareskog L, et al. 2015. Associations with smoking and shared epitope differ between IgA- and IgG-class antibodies to cyclic citrullinated peptides in early rheumatoid arthritis. Arthritis Rheumatol. 67:2032-37
148. Svendsen AJ, Kyvik KO, Houen G, Junker P, Christensen K, et al. 2013. On the origin of rheumatoid arthritis: the impact of environment and genes - a population based twin study. PLOS ONE 8:e57304
149. Syversen SW, Goll GL, van der Heijde D, Landewe R, Lie BA, et al. 2010. Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study. Ann. Rheum. Dis. 69:345-51
150. Terao C, Ikari K, Nakayamada S, Takahashi Y, Yamada R, et al. 2016. A twin study of rheumatoid arthritis in the Japanese population. Mod. Rheumatol. In press. doi: 10.3109/14397595.2015.1135856
151. Terao C, Ikari K, Ohmura K, Suzuki T, Iwamoto T, et al. 2012. Quantitative effect of HLA-DRB1 alleles to ACPA levels in Japanese rheumatoid arthritis: no strong genetic impact of shared epitope to ACPA levels after stratification of HLA-DRB1∗09:01. Ann. Rheum. Dis. 71:1095-97
152. Terao C, Ohmura K, Ikari K, Kochi Y, Maruya E, et al. 2012. ACPA-negative RA consists of two genetically distinct subsets based on RF positivity in Japanese. PLOS ONE 7:e40067
153. Terao C, Ohmura K, Katayama M, Takahashi M, Kokubo M, et al. 2011. Myelin basic protein as a novel genetic risk factor in rheumatoid arthritis - a genome-wide study combined with immunological analyses. PLOS ONE 6:e20457
154. Terao C, Ohmura K, Kochi Y, Ikari K, Maruya E, et al. 2011. A large-scale association study identified multiple HLA-DRB1 alleles associated with ACPA-negative rheumatoid arthritis in Japanese subjects. Ann. Rheum. Dis. 70:2134-39
155. Terao C, Ohmura K, Kochi Y, Ikari K, Okada Y, et al. 2015. Anti-citrullinated peptide/protein antibody (ACPA)-negative RA shares a large proportion of susceptibility loci with ACPA-positive RA: a metaanalysis of genome-wide association study in a Japanese population. Arthritis Res. Ther. 17:104
156. Terao C, Suzuki A, Ikari K, Kochi Y, Ohmura K, et al. 2015. An association between the 74th amino acid position of HLA-DRB1 and ACPA levels of Japanese ACPA-positive RA. Arthritis Rheumatol. 67:2038-45
157. Terao C, Yamada R, Ohmura K, Takahashi M, Kawaguchi T, et al. 2011. The human AIRE gene at chromosome 21q22 is a genetic determinant for the predisposition to rheumatoid arthritis in Japanese population. Hum. Mol. Genet. 20:2680-85
158. Terao C, Yano K, Ikari K, Furu M, Yamakawa N, et al. 2015. Main contribution of DRB1∗04:05 among the shared epitope alleles and involvement of DRB1 amino acid position 57 in association with joint destruction in anti-citrullinated protein antibody-positive rheumatoid arthritis. Arthritis Rheumatol. 67:1744-50
159. Texido G, Su IH, Mecklenbrauker I, Saijo K, Malek SN, et al. 2000. The B-cell-specific Src-family kinase Blk is dispensable for B-cell development and activation. Mol. Cell. Biol. 20:1227-33
160. Thomson W, Barton A, Ke X, Eyre S, Hinks A, et al. 2007. Rheumatoid arthritis association at 6q23. Nat. Genet. 39:1431-33
161. Tokuhiro S, Yamada R, Chang X, Suzuki A, Kochi Y, et al. 2003. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat. Genet. 35:341-48
162. Trowsdale J, Knight JC. 2013. Major histocompatibility complex genomics and human disease. Annu. Rev. Genom. Hum. Genet. 14:301-23
163. Trynka G, Sandor C, Han B, Xu H, Stranger BE, et al. 2013. Chromatinmarks identify critical cell types for fine mapping complex trait variants. Nat. Genet. 45:124-30
164. Umićević Mirkov, Mirkov M, Cui J, Vermeulen SH, Stahl EA, Toonen EJ, et al. 2013. Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritis. Ann. Rheum. Dis. 72:1375-81
165. van de Stadt LA, de Koning MH, van de Stadt RJ, Wolbink G, Dijkmans BA, et al. 2011. Development of the anti-citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritis. Arthritis Rheum. 63:3226-33
166. van der Helm-van Mil AH, Kern M, Gregersen PK, Huizinga TW. 2006. Variation in radiologic joint destruction in rheumatoid arthritis differs between monozygotic and dizygotic twins and pairs of unrelated patients. Arthritis Rheum. 54:2028-30
167. van der Helm-van Mil AH, Verpoort KN, le Cessie S, Huizinga TW, de Vries RR, Toes RE. 2007. The HLA-DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide. Arthritis Rheum. 56:425-32
168. van der Linden MP, Feitsma AL, le Cessie S, Kern M, Olsson LM, et al. 2009. Association of a singlenucleotide polymorphism in CD40 with the rate of joint destruction in rheumatoid arthritis. Arthritis Rheum. 60:2242-47
169. van der Woude D, Houwing-Duistermaat JJ, Toes RE, Huizinga TW, Thomson W, et al. 2009. Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibodynegative rheumatoid arthritis. Arthritis Rheum. 60:916-23
170. van Gaalen FA, van Aken J, Huizinga TW, Schreuder GM, Breedveld FC, et al. 2004. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. Arthritis Rheum. 50:2113-21
171. van Steenbergen HW, Rantapaa-Dahlqvist S, van Nies JA, Berglin E, Huizinga TW, et al. 2014. Does a genetic variant in FOXO3A predict amilder course of rheumatoid arthritis? Arthritis Rheumatol. 66:1678-81
172. Veal CD, Reekie KE, Lorentzen JC, Gregersen PK, Padyukov L, Brookes AJ. 2014. A 129-kb deletion on chromosome 12 confers substantial protection against rheumatoid arthritis, implicating the gene SLC2A3. Hum. Mutat. 35:248-56
173. Verpoort KN, Cheung K, Ioan-Facsinay A, van der Helm-van Mil AH, de Vries-Bouwstra JK, et al. 2007. Fine specificity of the anti-citrullinated protein antibody response is influenced by the shared epitope alleles. Arthritis Rheum. 56:3949-52
174. Verpoort KN, Papendrecht-van der Voort EA, van der Helm-van Mil AH, Jol-van der Zijde CM, van Tol MJ, et al. 2007. Association of smoking with the constitution of the anti-cyclic citrullinated peptide response in the absence of HLA-DRB1 shared epitope alleles. Arthritis Rheum. 56:2913-18
175. Verpoort KN, van Gaalen FA, van der Helm-van Mil AH, Schreuder GM, Breedveld FC, et al. 2005. Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis. Arthritis Rheum. 52:3058-62
176. Viatte S, Plant D, Bowes J, Lunt M, Eyre S, et al. 2012. Genetic markers of rheumatoid arthritis susceptibility in anti-citrullinated peptide antibody negative patients. Ann. Rheum. Dis. 71:1984-90
177. Viatte S, Plant D, Han B, Fu B, Yarwood A, et al. 2015. Association of HLA-DRB1 haplotypes with rheumatoid arthritis severity, mortality, and treatment response. JAMA 313:1645-56
178. Wang J, Bansal AT, Martin M, Germer S, Benayed R, et al. 2013. Genome-wide association analysis implicates the involvement of eight loci with response to tocilizumab for the treatment of rheumatoid arthritis. Pharmacogenom. J. 13:235-41
179. Wang Y, Shaked I, Stanford SM, Zhou W, Curtsinger JM, et al. 2013. The autoimmunity-associated gene PTPN22 potentiates Toll-like receptor-driven, type 1 interferon-dependent immunity. Immunity 39:111-22
180. Wordsworth P, Lanchbury JS, Sakkas LI, Welsh KI, Panayi GS, Bell JI. 1989. HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region. PNAS 86:10049-53
181. Wordsworth P, Pile KD, Buckely JD, Lanchbury JS, Ollier B, et al. 1992. HLAheterozygosity contributes to susceptibility to rheumatoid arthritis. Am. J. Hum. Genet. 51:585-91
182. Yang J, Lee SH, Goddard ME, Visscher PM. 2011. GCTA:a tool for genome-wide complex trait analysis. Am. J. Hum. Genet. 88:76-82
183. Yelamos J, Garcia-Lozano JR, Moreno I, Aguilera I, Gonzalez MF, et al. 1993. Association of HLADR4- Dw15 (DRB1∗0405) and DR10 with rheumatoid arthritis in a Spanish population. Arthritis Rheum. 36:811-14
184. Yu KH, See LC, Kuo CF, Chou IJ, Chou MJ. 2013. Prevalence and incidence in patients with autoimmune rheumatic diseases: a nationwide population-based study in Taiwan. Arthritis Care Res. 65:244-50
185. Zheng X, Shen J, Cox C, Wakefield JC, Ehm MG, et al. 2014. HIBAG - HLA genotype imputation with attribute bagging. Pharmacogenom. J. 14:192-200